We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$441M
AUM Growth
+$91.2M
Cap. Flow
+$74.4M
Cap. Flow %
16.88%
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$15.4M
2
STLA icon
Stellantis
STLA
+$9.9M
3
ALC icon
Alcon
ALC
+$7.77M
4
AMZN icon
Amazon
AMZN
+$6.64M
5
RACE icon
Ferrari
RACE
+$5.26M

Sector Composition

Rank Sector Weight
1 Miscellaneous 15.61%
2 Consumer Discretionary 15.26%
3 Technology 13.65%
4 Financials 12.86%
5 Healthcare 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUTU icon
226
Futu Holdings
FUTU
$15.3B
$413K 0.09%
3,057
+1,030
+51% +$150K
UBER icon
227
Uber
UBER
$146B
$412K 0.09%
8,573
-1,899
-18% -$99.2K
DHI icon
228
D.R. Horton
DHI
$39.3B
$412K 0.09%
4,761
+3,714
+355% +$349K
ASML icon
229
ASML
ASML
$611B
$412K 0.09%
+583
New +$385K
DXCM icon
230
DexCom
DXCM
$32.6B
$411K 0.09%
3,680
+720
+24% +$69.1K
OPA.U
231
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$409K 0.09%
41,000
ACTDU
232
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$404K 0.09%
40,000
LNG icon
233
Cheniere Energy
LNG
$56B
$404K 0.09%
+4,814
New +$392K
TER icon
234
Teradyne
TER
$51.4B
$400K 0.09%
3,153
-997
-24% -$128K
DB icon
235
PUT
Deutsche Bank
DB
$72.7B
$397K 0.09%
5,069
-2,711
-35% -$36.8K
CAG icon
236
Conagra Brands
CAG
$7.22B
$386K 0.09%
11,352
-1
-0% -$37
CELH icon
237
Celsius Holdings
CELH
$7.02B
$385K 0.09%
16,104
-5,154
-24% -$105K
EGO icon
238
Eldorado Gold
EGO
$10.5B
$383K 0.09%
39,267
+3,695
+10% +$41.1K
DD icon
239
DuPont de Nemours
DD
$17.2B
$383K 0.09%
3,860
-260
-6% -$26.1K
CLOU icon
240
Global X Cloud Computing ETF
CLOU
$366M
$382K 0.09%
13,340
KLAC icon
241
KLA
KLAC
$218B
$374K 0.08%
12,010
-6,480
-35% -$208K
TTWO icon
242
Take-Two Interactive
TTWO
$40B
$367K 0.08%
2,113
+75
+4% +$13.3K
DQ
243
Daqo New Energy
DQ
$763M
$359K 0.08%
4,964
+2,966
+148% +$213K
CIBR icon
244
First Trust NASDAQ Cybersecurity ETF
CIBR
$16.3B
$359K 0.08%
+7,500
New +$333K
CMCSA icon
245
Comcast
CMCSA
$87.5B
$358K 0.08%
6,200
+29
+0.5% +$1.62K
AOS icon
246
A.O. Smith
AOS
$7.78B
$355K 0.08%
5,004
-3,610
-42% -$249K
MTCH icon
247
Match Group
MTCH
$10.2B
$355K 0.08%
2,154
+68
+3% +$9.96K
PTH icon
248
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$283M
$353K 0.08%
6,348
+600
+10% +$31.2K
LLY icon
249
Eli Lilly
LLY
$1.01T
$352K 0.08%
1,498
+101
+7% +$20.3K
DNN icon
250
Denison Mines
DNN
$2.58B
$349K 0.08%
320,566
-236,455
-42% -$284K

Similar funds

Exane Derivatives's Q2 2021 Portfolio in Review

As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Exane Derivatives deployed $74.4M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.

By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.

  • Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
  • Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
  • Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
  • Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
  • Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
  • Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.